 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 3 | 1/1 | 返回列表 |
| 查看: 488 | 回復(fù): 2 | ||
審雨堂88銀蟲 (初入文壇)
|
[求助]
求助-湯森路透藥物報告 已有1人參與
|
|
求助Arbidol的湯森路透藥物報告，謝謝！ [ Last edited by 審雨堂88 on 2014-2-27 at 09:55 ] |
回復(fù)此樓» 猜你喜歡
藥學(xué)學(xué)碩326求調(diào)劑
已經(jīng)有0人回復(fù)
-
26年博士申請
已經(jīng)有20人回復(fù)
-
藥理學(xué)論文潤色/翻譯怎么收費?
已經(jīng)有126人回復(fù)
-
求調(diào)劑
已經(jīng)有1人回復(fù)
-
298求調(diào)劑一志愿中海洋
已經(jīng)有3人回復(fù)
-
求助 苯磷硫胺JP
已經(jīng)有0人回復(fù)
-
100金幣 阿莫西林克拉維酸鉀片BP藥典中提到的克拉維酸聚合物具體結(jié)構(gòu)式是啥？
已經(jīng)有2人回復(fù)
-
藥學(xué)調(diào)劑申請自薦信，一志愿中南大學(xué)
已經(jīng)有1人回復(fù)
-
藥學(xué)349專碩求調(diào)劑
已經(jīng)有1人回復(fù)
-
《左乙拉西坦注射液制備工藝研究、質(zhì)量控制和穩(wěn)定性研究》下載
已經(jīng)有1人回復(fù)
-
膳食補充劑合規(guī)性交流
已經(jīng)有0人回復(fù)
» 本主題相關(guān)價值貼推薦，對您同樣有幫助:
- 湯姆森數(shù)據(jù)庫求助
已經(jīng)有7人回復(fù)
- 求助一個湯姆森報告
已經(jīng)有3人回復(fù)
- 求助索利那新（solifenacin）和帕立骨化醇（paricalcitol） 的湯森路透報告
已經(jīng)有8人回復(fù)
- 湯森路透2014需要重點關(guān)注的藥物
已經(jīng)有449人回復(fù)
- 湯森路透-藥物化學(xué)在研發(fā)角色的轉(zhuǎn)變（2013年6月7日 ）【已搜索無重復(fù)】
已經(jīng)有164人回復(fù)
- 求：2013版的抗高血壓藥物市場研究報告~
已經(jīng)有5人回復(fù)
- 臨床前研究指南（CFDA和FDA，新的和舊的，共四個）
已經(jīng)有206人回復(fù)
- 求助湯森路透藥物研究報告
已經(jīng)有4人回復(fù)
- 求助關(guān)于藥物對照品的問題
已經(jīng)有18人回復(fù)
- 糖尿病藥物市場調(diào)查報告 2012
已經(jīng)有135人回復(fù)
- 降血脂藥物市場研究報告（2012年版）
已經(jīng)有411人回復(fù)
- 【求助】緩釋制劑臨床試驗
已經(jīng)有11人回復(fù)
- 【求助】請問醫(yī)藥信息調(diào)研報告包括哪些方面的內(nèi)容？
已經(jīng)有20人回復(fù)
- 【求助】有關(guān)中藥資源調(diào)查報告的問題
已經(jīng)有5人回復(fù)
- 【求助】求助一篇調(diào)查報告
已經(jīng)有9人回復(fù)
- 【求助】##藥物生產(chǎn)工藝技術(shù)可行性報告怎么寫
已經(jīng)有5人回復(fù)
- 【求助】想學(xué)計算機輔助藥物設(shè)計
已經(jīng)有28人回復(fù)
hlchenbetter
鐵桿木蟲 (正式寫手)
- 應(yīng)助: 2 (幼兒園)
- 金幣: 11540.6
- 紅花: 1
- 帖子: 311
- 在線: 162.6小時
- 蟲號: 1060733
- 注冊: 2010-07-19
【答案】應(yīng)助回帖
★ ★ ★ ★ ★
感謝參與，應(yīng)助指數(shù) +1
審雨堂88: 金幣+5, ★有幫助, 謝謝 2014-02-27 16:02:09
感謝參與，應(yīng)助指數(shù) +1
審雨堂88: 金幣+5, ★有幫助, 謝謝 2014-02-27 16:02:09
|
Accession No: 18965 Main Details Drug Name World Status Pharma Status Arbidol Launched Fully Launched Latest Change Updated On By Latest Change 3 Jun 1994 UN Minor change Company Status Data Originator Country Development Stage Non-industrial source Unspecified Launched Activity Data Therapy Description Code Therapy Status Immunostimulant, other I1Z Launched Antiviral, other J5Z Launched Pharmacology Description Code Immunostimulant IM+ Therapy Code Pharmacology Code I1Z J5Z IM+ IM+ Route of Administration Route of Administration Code Alimentary, po A-PO Indication Indication Status Infection, influenza virus Launched Target Data Target Name LocusLink/Entrez Gene ID Unspecified Unspecified -------------------------------------------------------------------------------- Target Family Group(s) Receptor > Cytokine receptor > Class II Chemical Data Origin of Material Code Description CH-SY Chemical, synthetic CAS Registry Number Rotatable Bonds Molecular Formula 131707-23-8 9 C22H26BrClN2O3S Hydrogen Bond Acceptors Hydrogen Bond Donors AlogP Molecular Weight 6 1 4.50 477.42 Chemical Name 1H-indole-3-carboxylic acid, 6-bromo-4-((dimethylamino)methyl)-5-hydroxy-1-methyl-2-((phenylthio)methyl)-, ethylester, monohydrochloride [CAS] Structure New Chemical Entity Yes Patent Data Country Number Priority Country Priority Date WO 9008135 WO 12 January 1989 Country Data Country Name Country Status Year Launched Licensing Op. Argentina - Yes Australia - Yes Austria - Yes Belgium - Yes Brazil - Yes Canada - Yes Chile - Yes China - Yes Colombia - Yes Denmark - Yes Finland - Yes France - Yes Germany - Yes Greece - Yes Hong Kong - Yes India - Yes Ireland - Yes Israel - Yes Italy - Yes Japan - Yes Luxembourg - Yes Malaysia - Yes Mexico - Yes Netherlands - Yes New Zealand - Yes Norway - Yes Peru - Yes Philippines - Yes Portugal - Yes Russian Federation Launched Yes South Africa - Yes South Korea - Yes Spain - Yes Sweden - Yes Switzerland - Yes Thailand - Yes Turkey - Yes UK - Yes USA - Yes Venezuela - Yes Major Events Event Date Act/Est Event Details 15 Oct 1992 Est New Product in Pharmaprojects 15 Oct 1992 Est Licensing Opportunities Worldwide Ratings Novelty Market Size Speed Total Established Strategy (2) US$ 0-500 million (1) Not available (0) Not available Detailed Information Arbidol is an interferon-inducer, developed by Dr I S Nikolaeva of the Centre for Chemistry of Drugs, VNIKhFI, Zubovskay Street 7, Moscow 119517, Russia, as a therapeutic and prophylactic for influenza A and B and other respiratory viral infections (Personal communication, Sep 1992). Marketing It is launched in Russia for therapeutic use in influenza A and B. Clinical Phase III In 2000 influenza patients, Arbidol 0.2g po tid or qid for 3 days reduced the duration of fever, catarrhal syndrome and overall disease, and prevented the development of post-influenzal complications. A prophylactic effect was achieved by 100mg twice/wk. It had an efficacy index of 5.16 (cf 1.0 for ramantadine) (18th Int Cong Chemother (Stockholm), 1993, Abs 190; Personal communication, Jun 1993). In 12 volunteers, 300mg/kg po produced interferon titres of 160IU/ml 24hr after administration (4th BICON (Prague), 1992, Abs 155). Preclinical In cell culture, it inhibited the plaque-forming activity of influenza virus without affecting its haemagglutinating activity. Licensing Arbidol is available for licensing worldwide (Personal communication, Sep 1992). |
2樓2014-02-27 10:17:11
審雨堂88
銀蟲 (初入文壇)
- 應(yīng)助: 0 (幼兒園)
- 金幣: 300.4
- 帖子: 48
- 在線: 152.8小時
- 蟲號: 1062270
- 注冊: 2010-07-22
- 專業(yè): 民族藥學(xué)
3樓2014-02-27 10:41:51
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 審雨堂88 的主題更新
| 3 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料專業(yè)求調(diào)劑 +11 | hanamiko 2026-03-18 | 11/550 |
|
|---|---|---|---|---|
|
[考研] 材料/農(nóng)業(yè)專業(yè)，07/08開頭均可，過線就行 +3 | 呵唔哦豁 2026-03-23 | 4/200 |
|
|
|
[考研] 327求調(diào)劑 +5 | prayer13 2026-03-23 | 5/250 |
|
|
|
[考研] 一志愿北京化工大學(xué) 070300 學(xué)碩 336分 求調(diào)劑 +6 | vv迷 2026-03-22 | 6/300 |
|
|
|
[論文投稿] 急發(fā)核心期刊論文 +3 | 賢達(dá)問津 2026-03-23 | 5/250 |
|
|
|
[考研] 一志愿南京理工大學(xué)085701資源與環(huán)境302分求調(diào)劑 +5 | 葵梓衛(wèi)隊 2026-03-18 | 7/350 |
|
|
|
[考研] 316求調(diào)劑 +7 | 梁茜雯 2026-03-19 | 7/350 |
|
|
|
[考研] 287求調(diào)劑 +8 | 晨昏線與星海 2026-03-19 | 9/450 |
|
|
|
[考研] 280求調(diào)劑 +11 | 咕嚕曉曉 2026-03-18 | 12/600 |
|
|
|
[考研] 材料工程專碩 348分求調(diào)劑 +3 | 冬辭. 2026-03-17 | 5/250 |
|
|
|
[考研] 279求調(diào)劑 +5 | 紅衣隱官 2026-03-21 | 5/250 |
|
|
|
[考研] 機械專碩299求調(diào)劑至材料 +3 | kkcoco25 2026-03-16 | 4/200 |
|
|
|
[考研] 材料 336 求調(diào)劑 +3 | An@. 2026-03-18 | 4/200 |
|
|
|
[考研] 22408 344分 求調(diào)劑 一志愿 華電計算機技術(shù) +4 | solanXXX 2026-03-20 | 4/200 |
|
|
|
[考研] 294求調(diào)劑材料與化工專碩 +15 | 陌の森林 2026-03-18 | 15/750 |
|
|
|
[考研] 一志愿中海洋材料工程專碩330分求調(diào)劑 +8 | 小材化本科 2026-03-18 | 8/400 |
|
|
|
[考研] 一志愿武漢理工材料工程專碩調(diào)劑 +9 | Doleres 2026-03-19 | 9/450 |
|
|
|
[考研] 290求調(diào)劑 +7 | ^O^乜 2026-03-19 | 7/350 |
|
|
|
[考研] 求調(diào)劑 +3 | eation27 2026-03-20 | 3/150 |
|
|
|
[考研]
 320求調(diào)劑0856
+3
|
不想起名字112 2026-03-19 | 3/150 |
|